ABCL - AbCellera - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

1.354B

Cash

796.5M

Avg Qtr Burn

N/A

Short % of Float

12.86%

Insider Ownership

28.64%

Institutional Own.

46.48%

Qtr Updated

03/31/23

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Bebtelovimab (LY-CoV1404) Details COVID-19	Approved Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Bamlanivimab (LY-CoV555) Details COVID-19	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.